Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Letter to the Editor

Volume 1, Number 5, December 2011, pages 234-236


The Treatment for Anti-insulin Antibody-mediated Immunological Insulin Resistance

Figure

Figure 1.
Figure 1. Changes in HbA1c and anti-insulin antibody125I-binding rate following the change in dose of insulin glulisine and insulin glargine in anti-insulin antibody-positive insulin-treated diabetic patient.

Table

Table 1. Reported Treatments for Anti-Insulin Antibody-Mediated Immunological Insulin Resistance and Hypoglycemia
 
Cessation of insulin administration [3]
Glucocorticoids [4]
Glucocorticoids / immunosuppressant / plasmapheresis [5]
Immunosuppressant / plasmapheresis [6]
Glucocorticoids / insulin linspro [7]
Insulin lispro [8]
Insulin glulisine [1]
Insulin glulisine / cessation of long-acting insulin analogs [2]